PlainRecalls
FDA Drug Low Class III Terminated

Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.

Reported: April 24, 2019 Initiated: April 2, 2019 #D-1252-2019

Product Description

Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.

Reason for Recall

Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.

Details

Recalling Firm
Johnson Matthey Inc.
Units Affected
416.95 g glass container
Distribution
Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.
Location
West Deptford, NJ

Frequently Asked Questions

What product was recalled?
Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.. Recalled by Johnson Matthey Inc.. Units affected: 416.95 g glass container.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 24, 2019. Severity: Low. Recall number: D-1252-2019.